This inventor holds 1 USPTO granted patent. Top assignee: Spofa, Spojene Podniky Pro Zdratvonickou Vyrobu. Active years: 1985.
Company Filing History:
Years Active: 1985
Title: Jaroslav Seifert: Innovator in Immunostimulatory Compounds
Introduction
Jaroslav Seifert is a notable inventor based in Prague, Czech Republic. He has made significant contributions to the field of immunology through his innovative work. His research focuses on compounds that exhibit immunostimulatory properties, which can have profound implications for medical science.
Latest Patents
Seifert holds a patent for L-Alanyl-D-isoglutamine adamantylamide. This compound is characterized by its unique formula, wherein AD represents a residue of adamantane bound in the number 1 position. The invention demonstrates an immunostimulatory and immunoadjuvant activity of unusual degree, without any relevant side effects such as pyrogenity. This patent highlights Seifert's commitment to advancing medical research and improving therapeutic options.
Career Highlights
Throughout his career, Jaroslav Seifert has been associated with Spofa, a company known for its contributions to the healthcare sector. His work at Spofa has allowed him to collaborate with other talented professionals in the field, further enhancing the impact of his inventions.
Collaborations
Seifert has worked alongside notable colleagues such as Martin Flegel and Milan Krojidlo. These collaborations have fostered an environment of innovation and creativity, leading to advancements in immunological research.
Conclusion
Jaroslav Seifert's contributions to the field of immunology through his patent for L-Alanyl-D-isoglutamine adamantylamide exemplify his dedication to scientific advancement. His work continues to inspire future innovations in the medical field.